Edmond S. Ma
1/F, 2 Village Road
Happy Valley, HWC, Hong Kong Special Administrative Region
Happy Valley, HWC, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical Evaluation of Xpert Xpress CoV-2/Flu/RSV plus and Alinity m Resp-4-Plex Assay.
Journal: Diagnostics (Basel, Switzerland)
Published: March 06, 2024
Clinical Evaluation of the BIOFIRE SPOTFIRE Respiratory Panel.
Journal: Viruses
Published: February 24, 2024
The Seasonality of Respiratory Viruses in a Hong Kong Hospital, 2014-2023.
Journal: Viruses
Published: August 13, 2023
Consensus Statements on Precision Oncology in the China Greater Bay Area.
Journal: JCO precision oncology
Published: June 14, 2023
Safety and Immunogenicity of a Booster Vaccination by CoronaVac or BNT162b2 in Previously Two-Dose Inactivated Virus Vaccinated Individuals with Negative Neutralizing Antibody.
Journal: Vaccines
Published: February 23, 2022
NGS4THAL, a One-Stop Molecular Diagnosis and Carrier Screening Tool for Thalassemia and Other Hemoglobinopathies by Next-Generation Sequencing.
Journal: The Journal of molecular diagnostics : JMD
Published: June 29, 2021
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults.
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults.
Journal: Blood cancer journal
Published: August 01, 2020
Draft Genome Sequence of Helicobacter cinaedi, Compiled by Direct Whole-Genome Sequencing of a Blood Culture-Positive Isolate in Hong Kong.
Journal: Microbiology resource announcements
Published: September 14, 2018
Prospective study on human fecal carriage of Enterobacteriaceae possessing mcr-1 and mcr-2 genes in a regional hospital in Hong Kong.
Journal: BMC infectious diseases
Published: June 28, 2017
Alpha thalassemia trait masquerading as hemoglobin H disease due to co-existing primary myelofibrosis.
Journal: Annals of hematology
Published: September 27, 2014
Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD.
Journal: Journal of hematology & oncology
Published: May 10, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026